Smital Shah's most recent trade in Pliant Therapeutics Inc was a trade of 26,764 Common Stock (Right to Buy) done . Disclosure was reported to the exchange on June 13, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pliant Therapeutics Inc | Smital Shah | Director | 13 Jun 2024 | 26,764 | 26,764 | - | - | Common Stock (Right to Buy) | ||
| Graphite Bio Inc | Smital Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Smital Shah | Director | 07 Jun 2023 | 14,000 | 14,000 | - | - | Stock Option (Right to Buy) | ||
| Graphite Bio Inc | Smital Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Smital Shah | Director | 16 Jun 2022 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | ||
| Pliant Therapeutics Inc | Smital Shah | Director | 29 Jun 2021 | 13,286 | 13,286 | - | - | Stock Option (right to buy) | ||
| Graphite Bio Inc | Smital Shah | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 93,585 | 93,585 | - | - | Stock Option (right to buy) | |
| Graphite Bio Inc | Smital Shah | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 15 Apr 2021 | 5,882 | 5,882 | - | 17 | 99,994 | Common Stock |